SmartWork Media Acquires ST Media Group Intl.
Sign of The Times, BXP, Screen Printing, Big Picture, VMSD, IRDC and BXP Live will build out SmartWork Media?s B2B portfolio.
“SmartWork Media has a stable of powerful award-winning B2B titles and is eager to build on this success. ST Media Group’s B2B titles are a seamless fit into SWM’s operations,” says Matthijs Braakman, CEO of SmartWork Media. “For more than 100 years, ST Media Group has positioned its B2B magazines, events and digital platforms as market leading products. SWM is proud to take ownership and build on the solid foundation of each brand. Our combined expertise will accelerate the transformation of all ST Media’s titles to leading-edge, dynamic and responsive multimedia content platforms to better serve the professional marketers in each unique industry.”
SmartWork Media’s portfolio of brands will expand from INSTORE, INVISION and PETS+ to include Signs of The Times, VMSD, Big Picture, BXP and Screen Printing. Each brand is supported by multimedia platforms including print magazines, websites, newsletters, content marketing services, live and virtual events (EyeInnovate, Pets+ Summit, IRDC, BXP Live), and other professional marketing solutions.
28 Valley Road, Suite 1, Montclair, NJ 07042
Matthijs Braakman, CEO
ABOUT SMARTWORK MEDIA: SmartWork Media is dedicated to the idea that business media should strive to inform, excite and inspire business readers, and that a good business magazine can (and should) have the energy and compulsive readability of a top consumer publication. The company publishes INSTORE, INVISION and PETS+ magazines as well as websites, events and media services for each industry.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SmartWork Media Acquires ST Media Group Intl. here
News-ID: 2134754 • Views: 438
More Releases for BXP
Favipiravir Market Provides in-depth analysis of the Industry, with Current Tren …
Favipiravir (T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Favipiravir was discovered through screening chemical library for anti-viral activity against the influenza virus by Toyama Chemical Co., Ltd. Favipiravir undergoes an intracellular phosphoribosylation to be an active form, favipiravir-RTP (favipiravir ribofuranosyl-5'-triphosphate), which is recognized as a substrate by RdRp, and inhibits the RNA polymerase activity. Since the catalytic domain of